Steffen Loft

Prof. Steffen Loft

Department of Public Health, Section of Environmental Health, University of Copenhagen, Øster Farimagsgade 5A, DK-1014 Copenhagen K, Denmark
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2005 in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Verified
Journal Article
Closed access
LRLotte Risom
Lotte Risom
PMPeter Møller
Peter Møller
Steffen LoftSteffen Loft
Steffen Loft

3 November 2009 in Free Radical Research
Verified
Journal Article
Closed access
PDF file
PMPeter Møller
Peter Møller
NJNicklas R. Jacobsen
Nicklas R. Jacobsen
JFJanne K. Folkmann
Janne K. Folkmann
PDPernille H. Danielsen
Pernille H. Danielsen
LMLone Mikkelsen
Lone Mikkelsen
Steffen LoftSteffen Loft
Steffen Loft
Particulates are small particles of solid or liquid suspended in liquid or air. In vitro studies show that particles generate reactive oxygen species, deplete endogenous antioxidants, alter mitochondrial function and produce oxidative damage to lipids and DNA. Surface area, reactivity and chemical composition play important roles in the oxidative potential of particulates. Studies in animal models indicate that particles from combustion processes (generated by combustion of wood or diesel oil), silicate, titanium dioxide and nanoparticles (C60 fullerenes and carbon nanotubes) produce elevated levels of lipid peroxidation products and oxidatively damaged DNA. Biomonitoring studies in humans have shown associations between exposure to air pollution and wood smoke particulates and oxidative damage to DNA, deoxynucleotides and lipids measured in leukocytes, plasma, urine and/or exhaled breath. The results indicate that oxidative stress and elevated levels of oxidatively altered biomolecules are important intermediate endpoints that may be useful markers in hazard characterization of particulates.

10 July 2008 in Environmental and Molecular Mutagenesis
Verified
Journal Article
Closed access
PDF file
NJNicklas Raun Jacobsen
Nicklas Raun Jacobsen
GPGiulio Pojana
Giulio Pojana
PWPaul A White
Paul A White
PMPeter Møller
Peter Møller
CCCorey Alexander Cohn
Corey Alexander Cohn
HWHåkan Wallin
Håkan Wallin

1 October 2014 in Mutation Research - Reviews in Mutation Research
Verified
Journal Article
Closed access
PMPETER MOLLER
PETER MOLLER
PDPernille Høgh Danielsen
Pernille Høgh Danielsen
DKDorina Gabriela Karottki
Dorina Gabriela Karottki
KJKim Jantzen
Kim Jantzen
MRMartin Roursgaard
Martin Roursgaard
Steffen LoftSteffen Loft
Steffen Loft

1 February 2015 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Open access
KKKristina Bram Knudsen
Kristina Bram Knudsen
HNHelle Northeved
Helle Northeved
PEPramod Kumar Ek
Pramod Kumar Ek
APAnders Permin
Anders Permin
TGTorben Gjetting
Torben Gjetting
MRMartin Roursgaard
Martin Roursgaard
This study investigated toxicity of nanocarriers comprised of cationic polymer and lipid components often used in gene and drug delivery, formulated as cationic micelles and liposomes. Rats were injected intravenously with 10, 25 or 100 mg/kg and sacrificed after 24 or 48 h, or 24 h after the last of three intravenous injections of 100 mg/kg every other day. Histological evaluation of liver, lung and spleen, clinical chemistry parameters, and hematology indicated little effect of treatment. DNA strand breaks were increased in the lung and spleen. Further, in the dose response study we found unaltered expression levels of genes in the antioxidant response (HMOX1) and repair of oxidized nucleobases (OGG1), whereas expression levels of cytokines (IL6, CXCL2 and CCL2) were elevated in lung, spleen or liver. The results indicate that assessment of genotoxicity and gene expression add information on toxicity of nanocarriers, which is not obtained by histology and hematology. This study investigates the toxicity of cationic micelles and liposomes utilized as nanocarriers in gene and drug delivery, demonstrating its effects on the lungs, spleen and liver.

15 February 2011 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
ZAZorana J. Andersen
Zorana J. Andersen
MHMartin Hvidberg
Martin Hvidberg
SJSteen Solvang Jensen
Steen Solvang Jensen
MKMatthias KETZEL
Matthias KETZEL
Steffen LoftSteffen Loft
Steffen Loft
OROle Raaschou-Nielsen
Ole Raaschou-Nielsen
Rationale: Short-term exposure to air pollution has been associated with exacerbation of chronic obstructive pulmonary disease (COPD), whereas the role of long-term exposures on the development of COPD is not yet fully understood. Objectives: We assessed the effect of exposure to traffic-related air pollution over 35 years on the incidence of COPD in a prospective cohort study. Methods: We followed 57,053 participants in the Danish Diet, Cancer, and Health cohort in the Hospital Discharge Register for their first hospital admission for COPD between 1993 and 2006. We estimated the annual mean levels of nitrogen dioxide (NO2) and nitrogen oxides (NOx) at all residential addresses of the cohort participants since 1971 to an event or 2006 and used indicators of traffic near the residential address at recruitment. We assessed the association between exposure to air pollution and COPD incidence by Cox regression analyses for the full cohort, and for participants with and without comorbid conditions, including asthma, diabetes, or cardiovascular disease. Measurements and Main Results: A first hospital admission for COPD was recorded for 1,786 (3.4%) of 52,799 eligible subjects between recruitment (1993–1997) and 2006. COPD incidence was associated with the 35-year mean NO2 level (hazard ratio, 1.08; 95% confidence interval, 1.02–1.14, per interquartile range of 5.8 μg/m3), with stronger associations in subjects with diabetes (1.29; 1.05–1.50) and asthma (1.19; 1.03–1.38). Conclusions: Long-term exposure to traffic-related air pollution may contribute to the development of COPD with possibly enhanced susceptibility in people with diabetes and asthma.